| Value | ₹114.0 Cr |
|---|
BSE filing, NSE: COVIDH. Summary written from the filing by ALFA Finder's alert engine.
iSERA Lifesciences Ltd: key numbers
- Share price
- ₹143.90
- Market cap
- ₹121.0 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹0.26 Cr
- P/E (TTM)
- 466.5×Sector 23.0×
- Promoter holding
- 55.07%-3.56% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from iSERA Lifesciences Ltd
All →iSERA Lifesciences Other Announcement
iSERA Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
iSERA Lifesciences Capital Structure Change
Promoter Pratap Dadasaheb Deshmukh acquired 86.13 lakh shares via preferential allotment. His stake in iSERA Lifesciences shifted to 55.07% following the company's capital restructuring.
iSERA Lifesciences Capital Structure Change
iSERA Lifesciences Limited approved the allotment of 1,61,82,800 equity shares on a preferential basis. The allotment, priced at Rs. 48.20 per share, total Rs. 78.00 Crore.
- Value
- ₹78.00 Cr
iSERA Lifesciences Annual General Meeting
iSERA Lifesciences Limited conducted its 34th Annual General Meeting on 29th September 2026, where shareholders adopted the audited financial statements and re-appointed a director.
iSERA Lifesciences Annual Report
iSERA Lifesciences Limited has submitted its Annual Report for the financial year 2025-26. The 34th Annual General Meeting is scheduled for September 29, 2026.
iSERA Lifesciences Annual General Meeting
iSERA Lifesciences has scheduled its 34th Annual General Meeting for September 29, 2026, and appointed a scrutinizer to oversee the voting process for the event.
Other capital structure change announcements
All →Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Womancart Capital Structure Change
Womancart Limited submitted its draft letter of offer for a rights issue of up to Rs.1,200 lakhs to eligible shareholders. The issue is pending in-principle approval from NSE Emerge, with the price, ratio and dates still blank.
- Value
- ₹12.00 Cr
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Blue Chip Tex Industries Capital Structure Change
Counter Cyclical Investments PMS sold 2,986 shares (0.15%) of Blue Chip Tex via open market, reducing its stake from 5.62% to 5.46%. The filing is a non-promoter SAST Reg 29(2) disclosure.